Furthermore, detrimental polymorphisms in the human SOD2 gene inhibiting processing of this antioxidant enzyme have been shown to be associated in T1D patients exhibiting various complications such as diabetic nephropathy (Houldsworth et al., 2015). The gene discussed is SOD2; the disease is type 1 diabetes mellitus.